News

The study of two drugs which are mixed sigma-1 agonists are designed to assess their anti-amnesic and neuroprotective effects. The study includes a model to which oligomeric amyloid

PBS’ single-use bioreactors will be used for R&D and production by the Korean firms. PBS’ bioreactors, which employ a low shear Air Wheel mixing mechanism, are utilized to

Presently, the drug is being under investigation in a Phase II SHELTER study as a second-line treatment for advanced hepatocellular carcinoma and in SAPHIRE Phase II study, as

The funds are expected to be used for product development and for commercializing the company’s prebiotic products for the dietary supplement and health food markets. Prebiotics are non-digestible

PPD‘s net income was $45.42m, compared to $20.98m for the same period in the prior year. The company has posted operating income of $57.15m for the second quarter

As per the terms of the deal, Astellas is eligible to get an undisclosed upfront payment from Merck along with development, regulatory and sales milestone. Earlier, Cardiome Pharma

The granting of certificate follows a proper inspection conducted by the Belgian authorities in May 2011. With this certification, Ablynx is now eligible to conduct preclinical testing and

Under the agreement, CSL has got the rights for using a cell line for the cGMP production of an undisclosed antibody. The licensed cell line was generated by

Gilead Sciences‘ net income was $746.23m, compared to $712.06m for the same period in the prior year. The company’s income from operations was $1.02bn for the second quarter